Remus Pharma Live Share Price Today, Share Analysis and Chart

Name: Remus Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Remus Pharmaceuticals Ltd.
Rating: 1.26966675
Author: Trendlyne DVM scores

about

Remus Pharmaceuticals is engaged in marketing and distribution of pharmaceuticals products and allied products.

655.00 -5.10 (-0.77%)

45.87% Fall from 52W High

4,300

NSE Volume

NSE 21 Jan, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Expensive Valuation

- / 100

Technically Bearish

28.1 / 100

No estimates available

Remus Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Remus Pharma Live Share Price Today, Share Analysis and Chart

Remus Pharmaceuticals is engaged in marketing and distribution of pharmaceuticals products and allied products.

45.87% Fall from 52W High

SWOT Analysis

Remus Pharma Live Price Chart